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We have generated a chimeric protein molecule 
composed of the a- and B-chains  of the MHC class I1 
I-E molecule fused to antibody V regions  derived 
from anti-human CD4  mAb  MT310. Expression  vec- 
tors were constructed containing the functional, 
rearranged gene segments coding  for the V region 
domains of the antibody H and L chains in place of 
the first domains of the complete structural genes 
of the I-E a- and B-chains,  respectively.  Cells trans- 
fected with both hybrid genes expressed a stable 
protein product on the cell surface. The  chimeric 
molecule exhibited the idiotype of the antibody 
MT310 as shown by binding to  the anti-idiotypic 
mAb  20-46. A protein of the anticipated molecular 
mass was  immunoprecipitated  with anti-mouse IgG 
antiserum. Furthermore, human soluble CD4 did 
bind to  the transfected cell line, demonstrating that 
the chimeric protein possessed the binding capacity 
of the original mAb. Thus, the hybrid  molecule  re- 
tained: 1) the properties of a MHC class I1 protein 
with  regard to correct chain assembly and  transport 
to  the cell surface: as well as 2) the Ag binding 
capacity of the antibody genes  used.  The generation 
of hybrid MHC class I1 molecules  with  highly spe- 
cific,  non-MHC-restricted  binding capacities will  be 
useful  for studying MHC class 11-mediated effector 
functions such as selection of the T cell repertoire 
in thymus of transgenic mice. 
Class I1 (Ia) MHC molecules I-A and I-E are heterodi- 
meric integral  membrane  proteins composed of nonco- 
valently linked a- (H chain)  and p- (L chain) glycoprotein 
chains.  Each  chain  consists of two extracytoplasmic do- 
mains of approximately 100 amino  acids,  with  the mem- 
brane proximal domain  showing  significant homology to 
Ig constant regions. These  are followed by a transmem- 
brane  and  short intracytoplasmic  segment for each a- or 
p-molecule (1). The expression of Ia Ag in thymus is 
restricted  to  epithelial  cells,  dendritic  cells, and macro- 
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phage-like cells, which play an  important role in the 
generation of class I1 MHC restriction and self tolerance 
of the T cell repertoire (2). 
Thymocytes and stromal cells interact via TCR and 
MHC molecule whose Ag binding groove has been occu- 
pied  by fragmented Ag (3). However, so-called superanti- 
gens like endogenous MLS proteins or exogenously de- 
rived staphylococcal enterotoxins  skew the T cell reper- 
toire by directly btnding  to specific @-chains of the TCR 
of thymocytes  (4). 
Imitating the capacity of superantigens to directly bind 
to  T cells and modulate the T cell repertoire, we envisaged 
a hybrid Ig-MHC class I1 molecule with the V regions of 
both chains of an antibody joined to the MHC class I1 LY- 
and 0-genes. respectively. These  constructs would exhibit 
three desirable properties. 1) They could bind any desired 
surface molecule on thymocytes, if the appropriate anti- 
body is chosen. 2)  The  structure of the  membrane proxi- 
mal protein domains of the MHC class I1 chains, as  well 
as  the  transmembrane  and cytoplasmic regions of these 
molecules would not be modified in these hybrid genes. 
Therefore, the biologic properties of the chimeric MHC 
class I1 proteins regarding intracellular  signaling would 
remain  unaltered. 3) The Ig-MHC class I1 molecules could 
be investigated in immunologically relevant tissues in 
vivo using  the  transgenic mouse technique. 
A basic  prerequisite for these  studies is to prove the 
correct assembly,  surface  expression, and Ag recognition 
of such a chimeric molecule. 
Chimeric molecules between different  members of the 
Ig superfamily  have been shown to be expressed on the 
cell surface, e.g., chimeras between MHC class I and MHC 
class I1 molecules (5), and hybrids between Ig and TCR 
chains (6). A class of novel proteins, the immunoadhes- 
ins, have been generated as chimeric molecules between 
different  members of the Ig superfamily and Ig domains 
Here we describe the construction of hybrid genes con- 
sisting of the MHC class I1 E a- and E 0-chains  and  the V
regions of the H and L chains of the  anti-human CD4 
mAb MT310. The  resulting hybrid protein is expressed 
on the cell surface of the  transfected cell line A20, is 
recognized  by anti-idiotypic antibody, and binds s C D ~ ~ .  
(71. 
MATERIALS  AND  METHODS 
Generation of Chlmerlc Genes 
VL and V, gene segments. Genomic phage clones containing 
rearranged  VJL  (phage KaWe 3/310) and VDJH  [phage HCWe 5/310) 
Abbreviation used in thls paper: sCD4. soluble CD4. 
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were derived from the murine anti-human CD4 mAb producing 
hybridoma MT310 (IgGlr) (W. Weissenhorn,  manuscript  in  prepa- 
ration).  The  2.6-kb EcoRI fragment  containing promotor sequences, 
VDJH. and the IgH chain enhancer was subcloned into plasmid 
pSPT 19. 
I-Ea- and &gene segments. A 7.5-kb KpnI subclone from the 
genomic cosmid clone LS3/15  contains  exons 3 to 6 of the I-EPb 
gene.  The  2-kb EcoRI subclone from this cosmid contains exon 2  (8). 
The  -3.2-kb End construct  contains  the  structural gene of the I-Ea 
chain  and  3.2  kb of 5”flanking  sequences (9). 
we cloned the  2.6-kb EcoRI fragment  containing leader and VDJH 
Hybrfd vectors. To generate  the VH containing chimeric  vector, 
into plasmid -3.2-kb Ea that had been cut with NcoI and BgZII 
domain). To enable selection for cell growth  in  the  presence of G418 
removing the promotor region. exon 1 and exon 2 (leader and a l -  
(GIBCO), the ClaI-PuuI fragment of cosmid vector pTCF (10)  contain- 
ing  the neomycin resistance  gene  was introduced into  the ClaI-Puul 
site of the VH-ECI hybrid  gene. 
duced the  2.5-kb HLndIII-EcoRI fragment of KaWe3/310 containing 
To generate  the VL containing chimeric vector VL-EP. we intro- 
the leader and VJ, and  about 200 bp of 5’-flanking region sequences 
into  the  SmaI  slte of the plasmid  pBluescript KS. The 7.5-kb KpnI 
fragment from cosmid clone LS 3/15  (exons 3 to 6 of I-E@) was  then 
cloned into  the HfndIII site of the vector. The HlndllI-SstI fragment 
of the CMV enhancer (1 1) was  inserted  into  the Not1 site. 
Transfectfon 
poration using a BTX Transfector 300 (Biotechnologies & Experi- 
The mouse  B cell lymphoma line A20 was  transfected by electro- 
mental  Research Inc.) set  at 300 V and  800 pF. After pulsing,  cells 
(1 x lo7 in PBS) were  plated at  2 x lo3 cells/well in 96-well plates. 
Medium containing  G418 (GIBCO) was added after  24 h at  a final 
concentration of 750 pgjml. 
Antfbodfes 
mAb MT310 (mouse lgG1K) recognizes human CD4 (12). mAb 20- 
46  (mouse  IgGlr)  was  raised  against mAb MT310 and  exhibits  anti- 
chains demonstrated that anti-idiotypic mAb 20-46 binds the H 
idiotypic reactivity. Transfection  experiments  with  different L 
chain of mAb MT310 separately. Additional mutational  analysis of 
the VH region of mAb MT310 showed that mAb 20-46 specifically 
reacts  against  the complementary determining region 3 (W. Weis- 
senhorn. manuscript in preparation). mAb 20-46 competes with 
available as mAb Dako T4  (Dakopatts). mAb MT310 does not block 
human CD4 for binding to mAb MT310. which is commercially 
mAb OKT4 (Ortho) from binding to  human CD4. demonstrating  their 
reactivity against  different epitopes (12). 
Flow-Cytometrfc Analysts 
Detection of the hybrid molecules on  the cell surface of transfec- 
tants  was performed by staining cell suspensions  with  fluorescent 
reagents  and visualizing them  on  the Becton-Dickinson flow cytom- 
eter FACS STAR. Cells (1 X lo6) in 100-pl PBS containing  2.5% FCS 
and 0.05% NaN, were incubated with 0.25 pg of anti-idiotypic mAb 
20-46 or negative  control  antibody MOPC 21 (IgG1. Sigma).  Second 
step reagent was fluorescein-conjugated rabbit anti-mouse IgGl 
(Cappel). Histograms represent  the log of fluorescence intensity vs 
cell number. 
To confirm  the Ag specificlty of our hybrid molecules, we incu- 
bated sCD4 (13) (gift of Biogen Inc.) at  0.2 @/lo0 pl in 96-well plates 
were stained  with mAb 20-46, OKT4-FITC (mouse IgG2b; Ortho), 
with 5 x 10’ transfectants  for  30 min at  4°C. After washing, cells 
and DakoT4-FITC (mouse IgG1; Dakopatts) as well as mAb MOPC 
141 (mouse IgG2b; Sigma) and MOPC 21 (mouse IgGl: Sigma) as 
negative  control after conjugation to FITC (Sigma). 
Imrnunopreclpttatlon 
Transfectants  (2 X lo7 cells) were labeled by culturing  them  for 4 
h in  the  presence of 0.3 mCi [35Sjmethionine (Amersham). Cell pellets 
were lysed at  4°C for 30 min in PBS containing  1%  Triton X-100 
and 2 mM PMSF. Lysates  were  precleared by incubation with  protein 
A-Sepharose CL-4B (Pharmacia) that had been preabsorbed with 
rabbit serum. Rabbit anti-mouse Ig (Dakopatts) or mAb 14-4-4s 
bated  with cell lysates  for 4 h at  4°C and  then collected by centrifu- 
(anti-I-Eak,d. IgG2a) was  absorbed  to protein  A-Sepharose and  incu- 
gation. After washing  in PBS containing  0.1 % Triton X- 100.  proteins 
were  eluted  from  protein  A-Sepharose. and endoglycosidase H (Boeh- 
ringer Mannheim)  treatment  was performed as described (14). One- 
dimensional SDS-PAGE through 10% gels was performed  according 
to  the method of Laemmli (1 5). Two-dimensionalgels were performed 
as described (16); 7.5 to  12.5% gradient  gels were run in the second 
dimension. 
RESULTS 
Construction of chimeric genes. Chimeric genes were 
constructed that encode the V regions of anti-human CD4 
mAb  MT310 (H and L chains) joined to the MHC class I1 
I-Ea and -p structural genes. For this purpose, genomic 
clones encoding the I-Ea and -/I chains were modified to 
permit the expression of rearranged Ig VDJH and VJ,. 
exons  in place of the  first  domains of the a- and p-chains 
of I-E, respectively. A schematic diagram of the resulting 
chimeric  genes is shown in Figure 1 (details are described 
in Materials and Methods). To express  these  chimeric 
genes in A20 cells, we preserved intact  the Ig regulatory 
enhancer/promotor  sequences of the VI, segment (1 7). To 
augment the VL promotor efficiency, we included the 
CMV enhancer  into  the xpression vector. 
Surface  expression of Ig-MHC class 11 hybrid genes 
in transfected A20 cells. The VI,-Ea and V,,-EP con- 
structs were cotransfected by electroporation into the B 
cell lymphoma line A20. This cell line is expressing MHC 
class I1 proteins and IgGZa. The Ig regulatory elements of 
our  constructs  should  therefore be suitable for expression 
in this cell type. After G418 selection, 78 stable clones 
were obtained. For recognition of the hybrid molecule on 
the cell surface of transfectants, we used anti-idiotypic 
mAb 20-46. Flow-cytometric analysis revealed eight pos- 
itive transfectants. The results for clone V310E15 are 
shown  in Figure 2e  as compared with negative transfec- 
tant VSloE3 (Figure 2a). All experiments described in  this 
publication were performed with two negative controls: 
negative transfectant V310E3 and cells of the A20 host 
cell line. A s  both gave identical results in all experiments, 
we document  here the  results for V3toE3 only. showing 
that  the  transfection  and G418 selection procedure did 
not  alter  the host cell line  to give unspecific binding of 
mAb 20-46. 
Correct translation  and  transport of the chimeric poly- 
peptide chains to the cell surface  was  further analyzed 
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VH-Ea (A)  and V,-E@ (B) constructs. Restriction enzymes above bars 
Ffgure 1 .  Schematic dlagram of the plasmids containlng the chimeric 
denote available restriction sites: restrlctlon sites lost during subcloning 
are Indicated below bars. Small bars represent the MHC class I1 structural 
gene segments (black boxes depict the 012 and 02. transmembrane, and 
cytoplasmlc domains). Large bars represent the Ig gene segments of H 
and L chain (black boxes illustrate leader and VDJ/VJ sequences: open 
Medfum-slzed bar represents neomycin resistance gene from cosmld 
boxes comprtse 5”flanking and intron sequences plus Ig enhancer in A).  
vector pTCF  in A and CMV enhancer in E.  
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Figure 2. Flow-cytometric analysis of transfectants V310E3 and 
V310E15. which were stained with mAb 20-46 (-), mAb  DakoT4 (. . . .). 
or mAb MOPC 21 (- - - -) a s  negative  control, followed by fluorescein- 
conjugated goat anti-mouse lgC1 (upper  panels). In the  lower  panels. 
cells were stained with fluorescein-conjugated mAb OKT4 I-) or MOPC 
with sCD4 before staining. 
141 (- - - -1 as negative  control. Cells in c. d. g. and h were incubated 
. -30Kd 
30- 
25- 
1 2 3 4 
from transfectants V3,0E3 (lanes 1 and 2) and V310E15 (lanes 3 and 4 )  
Figure 3. SDS-PACE on a  1 OW gel under  reducing  conditions.  Lysates 
were immunoprecipitated  with  rabbit  anti-mouse Ig. +. Cells treated  with 
endoglycosidase H. Molecular masses  are  indicated  in kDa. 
by immunoprecipitation of cell lysates  after  labeling  with 
[3"S]methionine.  Rabbit anti-mouse Ig bound to protein 
A-Sepharose was used as precipitating  agent. The  results 
for transfectants V3loE3 and V3,0E15 are presented in 
Figures 3 and 4. 
In contrast to negative transfectant V310E3 (Fig. 3. lane 
2). the immunoprecipitate of clone VnloEl 5 displayed two 
bands of about 33 kDa (weak)  and  31 kDa (strong),  re- 
spectively (Fig. 3. lane 4). These  bands did not  change 
molecular mass  after digestion with endoglycosidase H 
(Fig. 3, lane 3). providing evidence that  the protein chains 
had passed through the Golgi apparatus.  The  bands most 
likely comprise the a- and  @-chains of our hybrid molecule 
as the a- and  @-chains of intact I-E have been shown  to 
migrate in the range of about 30 to 35 kDa (18). The 
lower bands of about 23 kDa (Fig. 3, lanes 1 and 3) and 
26 kDa (Fig. 3, lanes 2 and 4) most probably represent 
endoglycosidase H sensitive free intracellular L chain, 
escaping the preclearing  procedure  with  protein A-Seph- 
arose. 
Two-dimensional gel electrophoresis of mAb 20-46 
precipitates from surface-expression positive transfec- 
tant V310E15 displayed three  sets of spots corresponding 
to the 33-, 3 1 -, and 26-kDa bands in the one-dimensional 
under  reducing  conditions.  Proteins  were resolved in  nonequilibrium pH 
Figure 4. Two-dimensional SDS-PACE on a 7.5 to 12.5% gradient gel 
gradient gel electrophoresis  in the horizontal  (basic  proteins on the left) 
and by SDS-PACE in the  vertical  dimension.  Lysates from transfectants 
V310E15 ( A )  and V310E3 (B) were  immunoprecipitated with rabbit  anti- 
of peptides. a and b. 33-kDa and 31-kDa hybrid molecule chains: c, I-E 
mouse  Igand  anti-I-E mAb 14-4-45. respectively. Lettersdenote position 
molecule peptides: n. n-chain: 0. +chain: d. invariant  chain: e. Ig L chain. 
analysis in Figure 3, lane 4. (Fig. 4A,  spots a. b, and e) .  
Deducing from the molecular mass, we assume  that  spots 
a and b in Figure 4A represent  the a- and  @-chains of the 
hybrid Ig-MHC class I1 molecule, with spot e most likely 
representing internal light chain protein that escaped 
preclearing. 
When immunoprecipitates by anti-I-E mAb 14-4-48 
of labeled lysates from clone V310E3 were analyzed by 
two-dimensional gel electrophoresis, the typical I-E pat- 
tern  was observed (Fig. 4B): I-E protein spots a t  33 kDa 
(a-chain) and 31 kDa (P-chain), and the coprecipitated 
invariant  chain (molecular mass, 3 1  kDa), located exactly 
as described by Jones et al. (1 9). Inasmuch as the labeling 
was  done with [35S]methionine. the I-E @-chain  shows  up 
considerably  weaker than  the  a-chain.  The  appearance 
of multiple isoelectric spots in the two-dimensional 
analysis is due to post-translational  carbohydrate modi- 
fication. Comparing the  immunoprecipitations of the Ig- 
MHC class I1 hybrid molecules by mAb 20-46  with the I- 
E  immunoprecipitations, we conclude that no  significant 
amounts of invariant chain or endogenous I-E protein 
were coprecipitated  together  with the hybrid molecules. 
Ig-MHC class I1 hybrid  molecules  retain Ag binding 
capacity. To test  the antibody specificity of the Ig-MHC 
class I1 hybrid molecules, we investigated whether the 
chimeric molecules on the cell surface have  retained the 
Ag binding  capacity of the  anti-human CD4 mAb MT310. 
Transfectants were incubated with sCD4 and subse- 
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quently  stained  with mAb 20-46,  anti-human CD4 mAb 
Okt4 or DakoT4. mAb DakoT4 is identical with mAb 
MT310 and commercially  available. OKT4 and DakoT4 
recognize different  epitopes  and do not  cross-block  each 
other (12). Soluble CD4 bound specifically to transfec- 
tants  should: 1) be accessible  to mAb OKT4, which  rec- 
ognizes a different  epitope  on sCD4; 2) block binding of 
mAb 20-46  to  transfectants as its idiotypic determinant 
on  the V region of mAb  MT310 is blocked by CD4 (E. P. 
Rieber,  unpublished  data):  and 3) not  be recognized by 
mAb DakoT4, because  the  chimeric cell surface  protein 
and mAb  DakoT4  use  identical V  regions thus recogniz- 
ing  identical  epitopes  on  the Ag. Flow-cytometric results 
as displayed  in  Figure  2  clearly  support  these  assump- 
tions: b and f show negative staining for mAb OKT4 
being  reversed  for  VBLOE 15 after  preincubation  with sCD4 
(h): positive staining of V3,,E15 with mAb 20-46 (e )  is 
greatly reduced after preincubation with sCD4 (9) .  As 
expected,  mAb  DakoT4  does  not  recognize sCD4 bound 
to  V310E15 (9, dotted line). 
DISCUSSION 
In this  article, we describe a novel class of MHC class 
I1 I-E molecules whose  binding  capacity  has  been modi- 
fied by replacing its N-terminal  domain  with  the  variable 
regions of a n  antibody. mAb  MT3 10 against  human CD4 
was  chosen as source of the Ig V  regions  because of the 
availability of: 1) anti-idiotypic antibodies specifically 
recognizing  mAb  MT310 for fast and efficient  screening 
of transfectants:  and 2) CD4 in soluble  form  to  demon- 
strate  the Ag specificity of our  construct. 
We designed MHC class I1 I-E constructs  with  the VH 
and VL regions of mAb  MT310 in  place of the  CY^ and 81 
domains of the CY and p chains of I-E, respectively.  Positive 
transfectants were  obtained  when  the  chimeric a- and p- 
chain genes were cotransfected into the mouse B cell 
lymphoma  line  A20.  There  might  be  several  reasons  for 
the  fact  that only  about  10% of the  stable G4 18  resistant 
clones  obtained in  our  transfection  showed  surface 
expression of the idiotype detectable by mAb 20-46. For 
once, we were using Ig promoters to drive our hybrid 
constructs,  aided by the homologous enhancer (V,) or by 
the heterologous CMV enhancer (VL). These promoter/ 
enhancer  pairs  should  express well in lymphoid  cells, but 
it  is  conceivable that  promoter/enhancer  pairs of dedi- 
cated  expression  vectors  (20) would express at a better 
rate. So were transfected Ig genes described to be ex- 
pressed a t  a reduced rate relative to hybridomas (21). 
Inasmuch as the  aim of our  experiments  was  to  determine 
whether it would be in principle  possible  to  express  the 
hybrid molecules on  the cell surface,  and  inasmuch as 
we obtained  eight  positive  clones  to test the  function of 
these molecules, we did not  further optimize the expres- 
sion of our  constructs. 
Surface expression of our chimeric molecules might 
seem  somewhat  surprising.  Previous  studies  have  docu- 
mented  allele-dependent  control of  MHC class I1 cell sur- 
face  expression. It was  found  that haplotype-matched a- 
and @-chains were transported to the membrane with 
high  efficiency,  whereas  haplotype-mismatched CY/@- 
pairs showed variable expression with most combina- 
tions yielding low to  intermediate  patterns  (22,  23).  Our 
results  indicate  that VH and VL regions  replacing  the  a1 
and p l  domains of I-Ea and -0, respectively,  do  not  impair 
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the protein  transport  mechanism  to  the cell membrane, 
which  is so easily  imbalanced  in  haplotype-mismatched 
MHC class I1 chain  pairs.  Endogenous MHC class I1 gene 
products do not  seem  to  interfere  with  the  assembly  and 
expression of our  hybrid molecules. In that  case,  reten- 
tion of hybrid  molecule chains together  with  endogenous 
I-Ea and -p chain molecules in  the  endoplasmic  reticulum 
would be expected, as happens with mismatched a/@- 
pairs. However, only trace amounts of endogenous 1-E 
protein  were  immunoprecipitated  together  with  the hy- 
brid  molecules. In addition, endoglycosidase H digestion 
of immunoprecipitates  reveals  the  great majority of hy- 
brid  molecules  being  resistent  to cleavage,  suggesting its 
transport  to  the cell surface  (24). We assume  that  this is 
also  true  when V regions of other  antibodies  are  used. 
Furthermore,  no  significant  amounts of invariant  chain 
were  coprecipitated  together  with the hybrid  molecules. 
Intact MHC class I1 molecules and  invariant  chain  have 
been  shown  to  associate  very  soon  after  their  synthesis 
in the endoplasmic reticulum (25). This association is 
thought  to  regulate  the  interaction  between processed Ag 
and MHC class I1 molecules during Ag presentation.  The 
lack of binding of invariant  chain  to  the  chimeric MHC 
class I1 molecules proves their unique conformational 
properties as acquired by the  antibody V regions. 
To maintain  the capability  for physiologic, MHC class 
11-like signal  transduction by our  hybrid molecules, we 
did not modify the 3"parts of the  structural  genes of I- 
Ea  and -p. This might be of importance,  inasmuch as it 
has  been  shown  that  truncated a- and  @-chains of I-Ak 
displayed  profound defects  in  intracytoplasmic  signaling 
Our  successful  attempts  to  express  chimeric MHC class 
I1 molecules that  exhibit  binding  capacity  to  natural MHC 
class I1 ligands  in a non-MHC-restricted manner pave the 
way for an  approach to design MHC molecules of any 
desired  specificity, provided that  such specificity can  be 
predefined by a mAb. Of particular interest are mAb 
specific  for T  cell-associated Ag involved in  the selection 
of the T cell repertoire  in vivo like the a/@-TCR, y/G-TCR, 
CD4 and CD8, or mAb with reactivity against specific 
TCR  v@ chains  (27, 28). Several of these  antibodies  have 
been  used  in  vitro  in thymus  organ  culture  experiments, 
and  distinct  effects  on  the T cell repertoire have been 
documented  (29,  30). 
In conclusion, we have described the feasibility of a 
system  designed  to  endow  antibody specificity to MHC 
class I1 molecules. We have  shown  the  correct  assembly, 
surface  expression,  and Ag recognition of such chimeric 
molecules and  discussed  future  applications of the  pre- 
sented  system. 
(26). 
1 .  
2. 
3. 
4 .  
5. 
6 .  
REFERENCES 
Kaufman, J. F.. C. Affray, A. J. Korman, D. A. Shackelford.  and J. 
Strominger. 1984.  The  class 11 molecules of the  human  and  murine 
Sprent, J., and S .  R. Webb. 1987.  Function  and  specificity of T  cell 
major histocompatibility  complex. Cell 36: 1. 
Schwartz. R. H. 1986. Immune response (Ir) genes of the murine 
subsets in the  mouse. Adu. Irnrnunol. 4 1 ~ 3 9 .  
Marrack, P.. and J. Kappler. 1990. The staphylococcal  enterotoxins 
major histocompatibility complex. Adu. irnmunol. 38:31. 
Golding. H., J. McCluskey, T. 1. Munitz, R. N. Germain. D. H. 
and their relatives. Science (Washington DC) 248:705. 
Margulies. and A. Singer. 1985. T-cell recognition of a chimeric 
class  Il/class 1 MHC molecule  and the role of L3T4. Nature (Lond.) 
3 I7:425. 
Goverman. J.. S. M. Gomez, K. D. Segesman. T. Hunkapiller, W. E. 
Laug,  and L. Hood. 1990. Chimeric immunoglobulin-T cell receptor 
276 CHIMERIC Ig-MHC CLASS I1 PROTEIN 
proteins  form  functional  receptors:  implications for T cell receptor 
complex formation and  activation. Cell 60:929. 
7. Capon. D. J., S. M. Chamow, J. Mordenti, S .  A. Marsters, T. Gregory, 
H. Mitsuya, R. A. Byrn, C. Lucas, F. M. Wurm, J. E. Groopman. S. 
Broder, and D. H. Smith. 1989. Designing CD4 immunoadhesins for 
AIDS therapy.  Nature (Lond.) 337:525. 
8. Widera, G . .  and R. A. Flavell. 1984. The  nucleotide  sequence of the 
murine I-Eflb immune  response  gene:  evidence  for  gene  conversion 
EMSO J. 3:1221. 
events in class 11 genes of the major histocompatibility complex. 
9. Widera, G.. L. C. Burkly. C. A. Pinkert, E. C. Bottger, C.  Cowing, R. 
Palmiter, R. L. Brinster, and R. A. Flavell. 1987 Transgenic mice 
selectively lacking MHC class I1 (I-E) antigen  expression on B cells: 
an in vivo approach to investigate la gene  function. Cell 51: 175. 
IO. Grosveld, F. G., T. Lund. E. J. Murray, A. L.  Mellor, H. H. M. Dahl, 
and R. A. Flavell. 1982. The  construction of cosmid libraries  which 
can be used to transform  eucaryotic cells. Nucleic  Acids  Res. 
10:6715. 
11. Boshart, M., F. Weber, G .  Jahn, K. Dorsch-Habler, B. Fleckenstein, 
and W. Schaffner. 1985. A very strong  enhancer is located upstream 
12. Sattentau, Q. J., A. G .  Dalgleish, P.  C. Weiss, and P. C. L. Beverley. 
of an immediate  early  gene of the cytomegalovirus. Cell 41:521. 
1986. Epitopes of the CD4 antigen  and HlV infection.  Science (Wash- 
13. Fisher. R. A., J. M. Bertonis. W. Meier, V. A. Johnson, D. S .  
ington DCJ 234: 1 120. 
Costopoulos, T. Liu. R. Tizard. B. Walker, M. S. Hirsch, R. T. 
Schooley. and R. A. Flavell. 1988. HIV infection is blocked in  vitro 
by recombinant  soluble CD4. Nature  ILond.J331:76. 
14. Sege, K., L. Rask. and P. A. Peterson. 1981. Role of betaz-micro- 
globulin in the intracellular processing of the HLA antigens. Bio- 
15. Laemmli, U. K. 1970. Cleavage of structural proteins during the 
chemistry  20:4523. 
16. Jones, P.  P. 1980. Analysis of radiolabeled lymphocyte  proteins by 
assembly of the  head of bacteriophage  T4.  Nature  (Lond.I227:680. 
one-  and  two-dimensional gel electrophoresis. In Selected  Methods 
in  Cellular  Immunology. 8. P. Mishell and S. P. Shigii,  eds.  Freeman, 
San  Francisco,  p. 398. 
17. Storb, U. 1987. Transgenic mice with immunoglobulin  genes.  Ann. 
18. Lawrance, S. K.. L. Karlsson, J. Price, V. Quaranta. Y. Ron, J. 
Rev. Imrnunol. 5:151. 
Sprent. and P. A. Peterson. 1989. Transgenic HLA DRu faithfully 
reconstitutes IE-controlled immune functions and induces cross- 
19. Jones, P. P.. D. B. Murphy, D. Hewgill, and H. 0. McDevitt. 1978. 
tolerance to Ea  in Eao mutant mice. Cell 58:563. 
Detection of a common polypeptide chain  in I-A and I-E subregion 
immunoprecipitates.  Immunochemfstry 16:51. 
20. Maniatis. T., E. F. Fritsch. and J. Sambrook. 1982. Molecular 
Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory. Cold 
21. Dorai. H.. and G .  P.  Moore. 1987. The  effect of dihydrofolate  reduc- 
Spring  Harbor, NY. 
tase-mediated  gene  amplification on the expression of transfected 
immunoglobulin  genes. J. Imrnunol. 139:4232. 
22.  Braunstein. N. S., and R. N. Germain. 1987. Allele-specific control 
a general model of la structure-function relationships. Proc. Natl. 
of la molecule surface  expression  and  conformation:  implications for 
Acad.  Sci. USA 84:2921. 
23. Germain, R. N., D. M. Bentley. and H. Quill. 1985. Influence of allelic 
MHC (Ia] molecules. Cell 43:233. 
polymorphism on the  assembly  and  surface  expression of class 11 
24. Kornfeld. R.. and S .  Kornfeld. 1985. Assembly of asparagine-linked 
25. Kvist. S. ,  K. Wiman. L. Claesson, P. A. Peterson, and B. Dobber- 
oligosaccharides.  Annu. Reu. Biochem. 54:63 1.  
stein. 1982. Membrane  insertion  and oligomeric assembly of HLA- 
DR histocompatibility  antigens. Cell 29:61. 
26. Nabavi. N.. 2. Ghogawala, A. Myer, J. Griffith, W. F. Wade. 2. 2. 
Chen, D. J. McKean. and L. H. Glimcher. 1989. Antigen presenta- 
tion abrogated  in cells expressing  truncated la molecules. J. Imrnu- 
not. 142:  1444. 
27. Kappler, J.. N. Roehm, and P. Marrack. 1987. T cell tolerance by 
clonal  elimination  in the  thymus. Cell 49:273. 
28. Staerz, U.. H. G. Rammensee, J. Benedetto. and M. Bevan. 1985. 
allotypic determinant on the T cell antigen receptor. J. Imrnunol. 
Characterization of a  murine monoclonal antibody specific for an 
134:3994. 
29. Born, W., M. McDuffie, N. Roehm. E. Kishnir, J. White, D. Thorpe. 
J. Stefano. J. Kappler, and P. Marrack. 1987. Expression and role 
of the T cell receptor  in  early  thymocyte  differentiation  in  vitro. J. 
30. Zepp, F., and U. D. Staerz.  1988. Thymic selection process  induced 
Imrnunol. 138:999. 
by hybrid  antibodies.  Nature (Lond.) 336:473. 
